Clinical characteristics and prognostic analysis of three hundred and nineteen cases of primary gastrointestinal diffuse large B-cell lymphoma

Figure 1 Stomach tissue protein expression. A: The hematoxylin and eosin; B: CD10 expression; C: B-cell lymphoma 6 expression; D: Multiple myeloma oncogene 1 expression; E: B-cell lymphoma 2 expression; F: Myelocytomatosis viral oncogene homolog expression; G: Ki-67 expression.

Figure 2 Intestinal tissue protein expression. A: The hematoxylin and eosin; B: CD10 expression; C: B-cell lymphoma 6 expression; D: Multiple myeloma oncogene 1 expression; E: B-cell lymphoma 2 expression; F: Myelocytomatosis viral oncogene homolog expression; G: Ki-67 expression.

Figure 3 Identification of the influencing factors by least absolute shrinkage and selection operator regression. A: Least absolute shrinkage and selection operator coefficient profiles of the 13 characteristics; B: The relationship curve between the partial likelihood deviation (binomial deviation) and log(λ).

Figure 4 Kaplan-Meier analysis. A: Patients re-stratified by risk score in the training cohort; B: Validation cohort. HR: Hazard ratio.

Figure 5 Time-dependent receiver operating characteristic analyses of the risk model. A: The training cohort; B: The validation cohort. TPR: True positive rate; FPR: False positive rate; AUC: Area under curve.

Figure 6 Decision curve analysis of the model performance. A: The training cohort; B: The validation cohort.